MSH|^~\&|SendAppName^2.16.840.1.114222.nnnn^ISO|Sending-Facility^2.16.840.1.114222.nnnn^ISO|PHINCDS^2.16.840.1.114222.4.3.2.10^ISO|PHIN^2.16.840.1.114222^ISO|20141225120030.1234-0500||ORU^R01^ORU_R01|CONSYPH_V1_0_TM_TC01|T|2.5.1|||||||||NOTF_ORU_v3.0^PHINProfileID^2.16.840.1.114222.4.10.3^ISO~Generic_MMG_V2.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISO~CongenitalSyphilis_MMG_V1.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISOPID|1||CONSYPH_TC01^^^SendAppName&2.16.840.1.114222.nnnn&ISO||~^^^^^^S||20130801|F||2054-5^Black or African American^CDCREC|^^^22^71301^^^^22079|||||||||||2186-5^Not Hispanic or Latino^CDCRECNK1|1||MTH^Mother^HL70063|^^^22^71301^USA^^^22079||||||||||S^Single^HL70002||19940113||||||||||||2186-5^Not Hispanic or Latino^CDCREC|||||||2054-5^Black or African American^CDCRECOBR|1||CONSYPH_TC01^SendAppName^2.16.840.1.114222.nnnn^ISO|68991-9^Epidemiologic Information^LN|||20130825170100|||||||||||||||20130825170100|||F||||||10316^Syphilis, Congenital^NNDOBX|1|CWE|78746-5^Country of Birth^LN||USA^United States^ISO3166_1||||||FOBX|2|CWE|77983-5^Country of Usual Residence^LN||USA^United States^ISO3166_1||||||FOBX|3|TS|11368-8^Date of Illness Onset^LN||20130801||||||FOBX|4|TS|77975-1^Diagnosis Date^LN||20130801||||||FOBX|5|CWE|77974-4^Hospitalized^LN||N^No^HL70136||||||FOBX|6|CWE|77978-5^Subject Died^LN||N^No^HL70136||||||FOBX|7|ST|77993-4^State Case Identifier^LN||<use state-assigned value>||||||FOBX|8|ST|77997-5^Legacy Case Identifier^LN||61528936181002006||||||FOBX|9|SN|77998-3^Age at Case Investigation^LN||^1|d^day^UCUM|||||FOBX|10|CWE|77982-7^Case Disease Imported Code^LN||PHC244^Indigenous, within jurisdiction^CDCPHINVS||||||FOBX|11|CWE|77984-3^Country of Exposure^LN|1|USA^United States^ISO3166_1||||||FOBX|12|CWE|77985-0^State or Province of Exposure^LN|1|22^Louisiana^FIPS5_2||||||FOBX|13|ST|77986-8^City of Exposure^LN|1|Alexandria||||||FOBX|14|ST|77987-6^County of Exposure^LN|1|Rapides||||||FOBX|15|CWE|77989-2^Transmission Mode^LN||417409004^Transplacental transmission^SCT||||||FOBX|16|CWE|77990-0^Case Class Status Code^LN||2931005^Probable diagnosis^SCT||||||FOBX|17|CWE|77965-2^Immediate National Notifiable Condition^LN||N^No^HL70136||||||FOBX|18|CWE|77980-1^Case Outbreak Indicator^LN||N^No^HL70136||||||FOBX|19|ST|77969-4^Jurisdiction Code^LN||S01||||||FOBX|20|CWE|48766-0^Reporting Source Type Code^LN||1^Hospital^HL70406||||||FOBX|21|ST|52831-5^Reporting Source Zip Code^LN||71301||||||FOBX|22|ST|74549-7^Person Reporting to CDC-Name^LN||Smith, John||||||FOBX|23|ST|74548-9^Person Reporting to CDC-Phone Number^LN||(734)677-7777||||||FOBX|24|DT|77979-3^Case Investigation Start Date^LN||20130801||||||FOBX|25|DT|77995-9^Date Reported^LN||20130801||||||FOBX|26|TS|77972-8^Earliest Date Reported to County^LN||20130802||||||FOBX|27|TS|77973-6^Earliest Date reported to State^LN||20130806||||||FOBX|28|SN|77991-8^MMWR Week^LN||^31||||||FOBX|29|DT|77992-6^MMWR Year^LN||2013||||||FOBX|30|DT|77970-2^Date First Reported to PHD^LN||20130802||||||FOBX|31|CWE|77966-0^Reporting State^LN||22^Louisiana^FIPS5_2||||||FOBX|32|CWE|77967-8^Reporting County^LN||22079^Rapides^FIPS6_4||||||FOBX|33|CWE|77968-6^National Reporting Jurisdiction^LN||22^Louisiana^FIPS5_2||||||FOBX|34|NM|75201-4^Number of Pregnancies^LN||1||||||FOBX|35|NM|75202-2^Number of Total Live Births^LN||1||||||FOBX|36|DT|75203-0^Last Menstrual Period^LN||99999999||||||FOBX|37|DT|75200-6^Date of First Prenatal Visit^LN||20130315||||||FOBX|38|CWE|75204-8^Prenatal Visit Indicator^LN||Y^Yes^HL70136||||||FOBX|39|CWE|75163-6^Trimester of First Prenatal Visit^LN||255247007^Second trimester^SCT||||||FOBX|40|CWE|75179-2^Mother's HIV Status During Pregnancy^LN||165815009^HIV negative^SCT||||||FOBX|41|CWE|75180-0^Mother's Clinical Stage of Syphilis During Pregnancy^LN||186867005^early latent^SCT||||||FOBX|42|CWE|75181-8^Mother's Surveillance Stage of Syphilis During Pregnancy^LN||PHC1506^Syphilis, early non-primary, non-secondary^CDCPHINVS||||||FOBX|43|DT|75182-6^Date When Mother Received Her First Dose of Benzathine Penicillin^LN||20130226||||||FOBX|44|CWE|75183-4^Trimester in Which Mother Received Her First Dose of Benzathine Penicillin^LN||255246003^First Trimester^SCT||||||FOBX|45|CWE|75184-2^Mother's Treatment^LN||PHC1278^2.4 M units benzathine penicillin^CDCPHINVS||||||FOBX|46|CWE|75185-9^Appropriate Serologic Reponse^LN||PHC1282^No, inappropriate response: evidence of treatment failure or reinfection^CDCPHINVS||||||FOBX|47|CWE|75164-4^Non-treponemal Test or Treponemal Test at First Prenatal Visit^LN||Y^Yes^HL70136||||||FOBX|48|CWE|75165-1^Non-treponemal Test or Treponemal Test at 28-32 Weeks Gestation^LN||Y^Yes^HL70136||||||FOBX|49|CWE|75166-9^Non-treponemal Test or Treponemal Test at Delivery^LN||Y^Yes^HL70136||||||FOBX|50|CWE|LAB588^Lab Test Performed Modifier^PHINQUESTION|2|STD150^Mother's First Non-treponemal Test Finding/Information^PHINQUESTION||||||FOBX|51|CWE|INV290^Test Type^PHINQUESTION|2|5292-8^VDRL (Serum)^LN||||||FOBX|52|CWE|INV291^Test Result^PHINQUESTION|2|11214006^Reactive^SCT||||||FOBX|53|CWE|STD123^Nontreponemal Serologic syphilis test result^PHINQUESTION|2|STD8^1:8^CDCPHINVS||||||FOBX|54|DT|82772-5^Date of lab result^LN|2|20130204||||||FOBX|55|CWE|LAB588^Lab Test Performed Modifier^PHINQUESTION|3|STD151^Mother's Most Recent Non-treponemal Test Finding/Information^PHINQUESTION||||||FOBX|56|CWE|INV290^Test Type^PHINQUESTION|3|20507-0^RPR^LN||||||FOBX|57|CWE|INV291^Test Result^PHINQUESTION|3|11214006^Reactive^SCT||||||FOBX|58|CWE|STD123^Nontreponemal Serologic syphilis test result^PHINQUESTION|3|STD8^1:8^CDCPHINVS||||||FOBX|59|DT|82772-5^Date of lab result^LN|3|20130808||||||FOBX|60|CWE|LAB588^Lab Test Performed Modifier^PHINQUESTION|4|STD152^Mother's First Treponemal Test Finding^PHINQUESTION||||||FOBX|61|CWE|INV290^Test Type^PHINQUESTION|4|24110-9^Treponema Pallidum - Enzyme immunoassay (EIA)^LN||||||FOBX|62|CWE|INV291^Test Result^PHINQUESTION|4|11214006^Reactive^SCT||||||FOBX|63|DT|82772-5^Date of lab result^LN|4|20130204||||||FOBX|64|CWE|LAB588^Lab Test Performed Modifier^PHINQUESTION|5|STD153^Mother's Most Recent Treponemal Test Finding^PHINQUESTION||||||FOBX|65|CWE|INV290^Test Type^PHINQUESTION|5|PHC1306^Other Treponemal Test Type^CDCPHINVS||||||FOBX|66|CWE|INV291^Test Result^PHINQUESTION|5|11214006^Reactive^SCT||||||FOBX|67|DT|82772-5^Date of lab result^LN|5|20130801||||||FOBX|68|CWE|LAB588^Lab Test Performed Modifier^PHINQUESTION|6|STD154^Infant's Non-treponemal Test Finding^PHINQUESTION||||||FOBX|69|CWE|INV290^Test Type^PHINQUESTION|6|20507-0^RPR^LN||||||FOBX|70|CWE|INV291^Test Result^PHINQUESTION|6|11214006^Reactive^SCT||||||FOBX|71|CWE|STD123^Nontreponemal Serologic syphilis test result^PHINQUESTION|6|STD1^1:1^CDCPHINVS||||||FOBX|72|DT|82772-5^Date of lab result^LN|6|20130801||||||FOBX|73|CWE|LAB588^Lab Test Performed Modifier^PHINQUESTION|7|STD155^Infant's Treponemal Test Finding^PHINQUESTION||||||FOBX|74|CWE|INV290^Test Type^PHINQUESTION|7|24110-9^Treponema Pallidum - Enzyme immunoassay (EIA)^LN||||||FOBX|75|CWE|INV291^Test Result^PHINQUESTION|7|11214006^Reactive^SCT||||||FOBX|76|DT|82772-5^Date of lab result^LN|7|20130801||||||FOBX|77|CWE|75186-7^Vital Status^LN||438949009^Alive^SCT||||||FOBX|78|SN|56056-5^Birth Weight^LN||^2623|g^gram^UCUM|||||FOBX|79|SN|57714-8^Gestational Age^LN||^36|wk^week^UCUM|||||FOBX|80|CWE|75193-3^Clinical Signs of Congenital Syphilis^SCT||84387000^no signs/asymptomatic^SCT||||||FOBX|81|CWE|75194-1^Long Bone X-rays for Infant^LN||PHC1288^Yes, no signs of CS^CDCPHINVS||||||FOBX|82|CWE|75192-5^Darkfield Exam, DFA, or Special Stain Test Findings^LN||373121007^Test Not done^SCT||||||FOBX|83|CWE|LP48341-9^CSF WBC Count^LN||373121007^Test Not done^SCT||||||FOBX|84|CWE|LP69956-8^CSF Protein Level^LN||373121007^Test Not done^SCT||||||FOBX|85|CWE|75195-8^CSF VDRL Test Finding^LN||373121007^Test Not done^SCT||||||FOBX|86|CWE|75197-4^Infant Treated^LN||PHC1296^Yes,with other treatment^CDCPHINVS||||||FOBX|87|CWE|75207-1^Stillbirth Indicator^LN||N^No^HL70136||||||FOBR|2|CSYP23456-1^EHR^2.16.840.1.113883.19.3.2.3^ISO|CSYP9700123-1^Lab^2.16.840.1.113883.19.3.1.6^ISO|31147-2^Reagin Ab [Titer] in Serum by RPR^LN|||20130801000000|||||||||121121121^^^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD||||||20130801000000|||F||||||A53.9^Syphilis, unspecified^I10COBX|1|SN|31147-2^Reagin Ab [Titer] in Serum by RPR^LN||^1^:^4|{titer}^titer^UCUM|<1:1|H|||F|||20130801|||0021^Rapid Agglutination^OBSMETHOD||20130801||||GHH Lab^L^^^^CLIA&2.16.840.1.113883.19.4.6&ISO^XX^^^1236||9876543^^^^^^^^NPI&1.3.6.1.4.1.562.2.4.1.43&ISO^^^^NPINTE|1|L|Response to therapy is indicated by a > or =4-fold decrease in titer between pre and post treatment samples. However, a significant decrease in RPR titers may not occur for months to years following treatment, some patients may show persistent, low-level titers (e.g. serofast) despite adequate therapy.SPM|1|CSYP234561-1&EHR&2.16.840.1.113883.19.3.2.3&ISO^CSYP97001222-1&Lab&2.16.840.1.113883.19.3.1.6&ISO||119364003^Serum specimen^SCT||||368149001^Right Elbow^SCT|||P^Patient^HL70369||||||20130801|20130801